Real-World Data Collab Aims to Improve Diversity in Cancer Clinical Trials
Louisiana State University Health New Orleans is partnering with ConcertAI to address access to and diversity in cancer clinical trials.
Source: Getty Images
By - The National Cancer Institute Community Oncology Research Program (NCI NCORP)-designated Louisiana State University (LSU) Health New Orleans is collaborating with artificial intelligence (AI) and real-world data solutions company ConcertAI to improve diversity in clinical trials and ensure broader access for cancer patients.
The collaboration is part of ongoing work by LSU Health New Orleans and NCI NCORP to establish and improve the clinical trials network in the Gulf South region. According to the press release, NCI awarded LSU Health New Orleans a $5.6 million grant to create the network and another $13.6 million to expand it, with an emphasis on reaching underserved and minority patients. The collaboration also aligns with ConcertAI’s ERACE (Engaging Research to Achieve Cancer Care Equality) program.
"The collaboration will identify current cancer care disparities in Louisiana and how they can be addressed," said Augusto Ochoa, MD, an LSU Health New Orleans NCORP principal investigator, in the press release. "Insights gleaned from the novel real-world data advanced by the partnership will lead to evidence-based strategies to reduce health inequities among populations with existing disparities, including the implementation of AI-based capabilities to improve patient screening, engagement and recruitment at clinical trial sites throughout the region."
